Your browser doesn't support javascript.
loading
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma.
Ingham, Matthew; Lee, Shing; Van Tine, Brian A; Choy, Edwin; Oza, Jay; Doshi, Sahil; Ge, Liner; Oppelt, Peter; Cote, Gregory; Corgiat, Brian; Sender, Naomi; Sta Ana, Sarah; Panchalingam, Lavan; Petricoin, Emmanuel; Schwartz, Gary K.
Afiliación
  • Ingham M; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
  • Lee S; Department of Biostatistics, Mailman School of Public Health, New York, New York.
  • Van Tine BA; Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Choy E; Division of Hematology and Medical Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Oza J; Bristol Myers Squibb, Princeton, New Jersey.
  • Doshi S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ge L; Department of Biostatistics, Mailman School of Public Health, New York, New York.
  • Oppelt P; Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Cote G; Division of Hematology and Medical Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Corgiat B; Theralink Technologies, Baton Rouge, Louisiana.
  • Sender N; Clinical Data and Protocol Management Office, Columbia University Irving Medical Center, New York, New York.
  • Sta Ana S; Clinical Data and Protocol Management Office, Columbia University Irving Medical Center, New York, New York.
  • Panchalingam L; Clinical Data and Protocol Management Office, Columbia University Irving Medical Center, New York, New York.
  • Petricoin E; Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, Virginia.
  • Schwartz GK; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
Clin Cancer Res ; 29(6): 1031-1039, 2023 03 14.
Article en En | MEDLINE | ID: mdl-36548343
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipopolisacáridos / Liposarcoma Tipo de estudio: Clinical_trials Límite: Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipopolisacáridos / Liposarcoma Tipo de estudio: Clinical_trials Límite: Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos